ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

ABVC 11.14.2024

Full Press ReleaseSEC FilingsOur ABVC Tweets

About Gravity Analytica

Recent News

  • 12.16.2024 - ๐—•๐—ฟ๐—ถ๐—ฑ๐—ด๐—ถ๐—ป๐—ด ๐—ง๐˜„๐—ผ ๐—ช๐—ผ๐—ฟ๐—น๐—ฑ๐˜€: ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—”๐˜€๐—ฝ๐—ถ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป๐—ฎ๐—น๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฆ๐˜๐˜‚๐—ฑ๐—ฒ๐—ป๐˜๐˜€ ๐—–๐—ผ๐—ป๐˜€๐—ถ๐—ฑ๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐—ง๐—ฎ๐—ถ๐˜„๐—ฎ๐—ป
  • 11.14.2024 - ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
  • 08.28.2024 - Indian Talent in Taiwan

Recent Filings

  • 01.13.2025 - 8-K/A Current report
  • 11.15.2024 - 424B4 Prospectus [Rule 424(b)(4)]
  • 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLCโ€™s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on anโ€œas isโ€ and โ€œas availableโ€ basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com